It is the time of the year again that scientists around the world get together and discuss interesting and cutting edge scientific ideas, processes and applications. Rapid Novor is no exceptions and we are heading to San Antonio in only a few weeks time.
We invite you to the Novor booth #206 for a brief chat with our scientists and see why REAL de novo antibody protein sequencing matters. You can schedule a meeting with us by sending emails to support@rapidnovor.com.
We will present a poster MP018, In-Depth Characterization of Monoclonal Antibodies with a Single Experiment and Fully Automated Data Analysis, at this year’s conference. In the poster, we demonstrate the power of REAL de novo sequencing. To spice it up, we also identified and quantified the glycan forms which conforming to the published glycan structure.
If you are unable to attend ASMS this year, book a free consultation with us and we will walk you through the perks you will receive from our offerings.
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics